Press Releases

Filter by Category

Filter by Program

Filter by Publish Date

C-Path to Lead Novel Pre-Consortium Framework for Optimizing the Rare and Orphan Medical Product Lifecycle

TUCSON, Ariz., April 28, 2022 — Critical Path Institute (C-Path), in collaboration with one of the industry’s prominent r

TUCSON, Ariz., April 14, 2022 – Critical Path Institute (C-Path) has named Sergey Rakhilin, Ph.D., as Executive Director of its

TUCSON, Ariz., April 5, 2022 — Critical Path Institute’s (C-Path) Type 1 Diabetes Consortium (T1DC) today announced that the E

C-Path in Europe works seamlessly with its U.S. counterpart to advance the development of novel regulatory-endorsed methodologies

The endeavor represents a major milestone for C-Path TUCSON, Ariz., March 10, 2022 — Critical Path Institute (C-Path) and

PARIS, France and TUCSON, Ariz., U.S., February 1, 2022 — Critical Path Institute (C-Path), an independent global nonprofit orga

Dr. Lindsey Murray will lead C-Path’s New Rare Disease COA Consortium TUCSON, Ariz., January 13, 2022 — Critical Path Institut

The Rare Disease COA Consortium aims to advance patient-focused assessment of clinical benefit in treatment trials for rare diseas

TUCSON, Ariz., January 11, 2022 — Critical Path Institute (C-Path) is pleased to announce the Electronic Patient-Report

TUCSON, Ariz., Dec. 1, 2021 — Critical Path Institute’s (C-Path) International Neonatal Consortium (INC) today announced a sem